Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butyrate Supplement in Rheumatoid Arthritis
NCT05576597Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium butyrate in rheumatoid arthritis (RA), sponsored by Peking University People's Hospital. Started Aug 2022; status: completed.
02
Drugs
sodium butyrate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05576597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05576597.